Skip to content
Every 3 seconds, one person worldwide develops dementia. With an estimated 5.9 million Americans living with dementia today, and 44 million people living with […]
With the deadly threat of drug-resistant infections increasing daily, we desperately need actions to address the broken commercial marketplace for novel antimicrobials—including the PASTEUR
Legislation to fight AMR superbugs is an urgent need, BIO member tells Senate hearing Read More »
The Senate Health, Education, Labor, and Pensions (HELP) Committee released a bipartisan discussion draft of the Pandemic and All-Hazards Preparedness Act (PAHPA) reauthorization bill
Senate HELP’s PAHPA draft: The good, the bad, and the ugly Read More »
During the 2023 BIO International Convention, the Biotechnology Innovation Organization (BIO) released its seventh-annual best practices report, “The U.S. Biosciences Industry in the States:
How can states grow their biosciences sectors? Read More »
Healthcare on the African continent is changing. “At the current pace, the annual rate of cancer in Africa is projected to reach 1.4 million
How do we achieve the cancer moonshot in Africa? Read More »
Psychedelics have established themselves as a game changer in the drug development space in recent years. And it is not just scientists who are
Psychedelics ‘do things in the brain that nothing else does’ Read More »
“We all just went through a pandemic together,” began Phyllis Arthur, Vice President of Infectious Disease & Emerging Science Policy at the Biotechnology Innovation
How can we increase routine adult vaccination? Read More »
The disease burden of RSV has been a tough problem for biotech R&D to solve for over 60 years. However, within the last year,
We’re conquering RSV for the young and old – but more innovation is needed Read More »
Cancer is less the death sentence that it used to be. That does not mean that cancer treatment can’t be profoundly life-altering or that
NIH Innovation Zone: Meet Privo Technologies Read More »
Patient stories and relationships are at the heart of state advocacy. “A lot of policymakers are just not aware of what our companies are,
How to build a state or regional advocacy arm Read More »
